Bis-naphthalimides: a new class of antitumor agents. 1993

M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
Laboratorios Knoll S. A, Madrid, Spain.

A series of bis-intercalators bearing the 1,8-naphthalimide chromophore has been synthesized and in vitro activities determined. Most compounds have higher activities in HT-29 than the leader compounds Mitonafide and Amonafide. One of them (22) was selected for in vivo studies and presents an interesting activity in MX-1 and OVCAR models. (22) also acts as antitopoisomerase II.

UI MeSH Term Description Entries
D007094 Imides Organic compounds containing two acyl groups bound to NITROGEN. Imide
D007364 Intercalating Agents Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. Intercalating Agent,Intercalating Ligand,Intercalative Compound,Intercalator,Intercalators,Intercalating Ligands,Intercalative Compounds,Agent, Intercalating,Agents, Intercalating,Compound, Intercalative,Compounds, Intercalative,Ligand, Intercalating,Ligands, Intercalating
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
July 1998, IDrugs : the investigational drugs journal,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1995, Cancer investigation,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1996, Experientia,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1983, Pharmacology & therapeutics,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
November 2003, Bosnian journal of basic medical sciences,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
May 2009, Expert opinion on drug discovery,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1981, Planta medica,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1984, Neoplasma,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
January 1996, Journal de pharmacie de Belgique,
M F Braña, and J M Castellano, and M Morán, and M J Pérez de Vega, and C R Romerdahl, and X D Qian, and P Bousquet, and F Emling, and E Schlick, and G Keilhauer
April 1988, Journal of medicinal chemistry,
Copied contents to your clipboard!